drugset / Trial / NCT06616922
Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a phase II, randomized, parallel-group, blinded-assessor, multicentre study to assess the non-inferiority of RD03/2016 eye drops vs. levofloxacin eye drops alone (1:1) in microbiological eradication in patients with a clinical diagnosis of bacterial conjunctivitis with moderate/severe signs.
Timeline
- Start
- 2021-11-05
- Primary completion
- 2023-06-14
- Completion
- 2023-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac Tromethamine | Small molecule | 0.5 % | Other |
| Comparator | Levofloxacin | Small molecule | 0.5 % | Other |